Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EBIT 2010-2025 | BMY

Bristol Myers Squibb annual and quarterly EBIT history from 2010 to 2025. EBIT can be defined as earnings before interest and taxes.
  • Bristol Myers Squibb EBIT for the quarter ending March 31, 2025 was $2.970B, a 125.79% decline year-over-year.
  • Bristol Myers Squibb EBIT for the twelve months ending March 31, 2025 was $6.107B, a 204.46% decline year-over-year.
  • Bristol Myers Squibb 2024 annual EBIT was $-8.379B, a 199.28% decline from 2023.
  • Bristol Myers Squibb 2023 annual EBIT was $8.44B, a 9.43% increase from 2022.
  • Bristol Myers Squibb 2022 annual EBIT was $7.713B, a 4.75% decline from 2021.
  
Bristol Myers Squibb Annual EBIT
(Millions of US $)
2024 $-8,379
2023 $8,440
2022 $7,713
2021 $8,098
2020 $-6,871
2019 $4,975
2018 $5,968
2017 $5,131
2016 $5,915
2015 $2,077
2014 $2,381
2013 $2,891
2012 $4,170
2011 $6,981
2010 $6,071
2009 $5,320
Bristol Myers Squibb Quarterly EBIT
(Millions of US $)
2025-03-31 $2,970
2024-12-31 $175
2024-09-30 $1,676
2024-06-30 $1,286
2024-03-31 $-11,516
2023-12-31 $1,674
2023-09-30 $2,137
2023-06-30 $1,859
2023-03-31 $2,770
2022-12-31 $1,859
2022-09-30 $2,209
2022-06-30 $1,958
2022-03-31 $1,687
2021-12-31 $1,858
2021-09-30 $2,157
2021-06-30 $1,553
2021-03-31 $2,530
2020-12-31 $-10,451
2020-09-30 $2,257
2020-06-30 $1,627
2020-03-31 $-304
2019-12-31 $-129
2019-09-30 $1,349
2019-06-30 $1,776
2019-03-31 $1,979
2018-12-31 $1,505
2018-09-30 $2,167
2018-06-30 $517
2018-03-31 $1,779
2017-12-31 $698
2017-09-30 $1,183
2017-06-30 $1,295
2017-03-31 $1,955
2016-12-31 $1,086
2016-09-30 $1,559
2016-06-30 $1,615
2016-03-31 $1,655
2015-12-31 $-410
2015-09-30 $987
2015-06-30 $52
2015-03-31 $1,448
2014-12-31 $-60
2014-09-30 $1,008
2014-06-30 $448
2014-03-31 $985
2013-12-31 $869
2013-09-30 $818
2013-06-30 $530
2013-03-31 $674
2012-12-31 $513
2012-09-30 $571
2012-06-30 $1,059
2012-03-31 $2,027
2011-12-31 $1,717
2011-09-30 $1,767
2011-06-30 $1,768
2011-03-31 $1,729
2010-12-31 $1,593
2010-09-30 $1,581
2010-06-30 $1,531
2010-03-31 $1,366
2009-12-31 $1,252
2009-09-30 $1,477
2009-06-30 $1,419
2009-03-31 $1,172
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $95.344B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $218.361B 16.30
Amgen (AMGN) United States $146.073B 13.09
Gilead Sciences (GILD) United States $133.561B 13.87
Vertex Pharmaceuticals (VRTX) United States $111.964B 0.00
GSK (GSK) United Kingdom $79.765B 9.48
CSL (CSLLY) Australia $77.232B 0.00
Regeneron Pharmaceuticals (REGN) United States $63.520B 15.42
Alnylam Pharmaceuticals (ALNY) United States $37.807B 0.00
Argenex SE (ARGX) Netherlands $35.879B 97.93
BeiGene (ONC) Cayman Islands $23.961B 0.00
BioNTech SE (BNTX) Germany $23.722B 0.00
Biogen (BIIB) United States $18.435B 7.95
Royalty Pharma (RPRX) United States $18.245B 7.71
Genmab (GNMSF) Denmark $13.767B 14.08
Genmab (GMAB) Denmark $13.343B 14.97
Illumina (ILMN) United States $12.723B 24.14
Incyte (INCY) United States $12.436B 94.48
Insmed (INSM) United States $12.300B 0.00
Exelixis (EXEL) United States $11.560B 19.62
BioMarin Pharmaceutical (BMRN) United States $11.037B 17.93
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Exact Sciences (EXAS) United States $10.743B 0.00
Moderna (MRNA) United States $10.156B 0.00
Ascendis Pharma (ASND) Denmark $9.877B 0.00
QIAGEN (QGEN) Netherlands $9.347B 18.19
Roivant Sciences (ROIV) United Kingdom $7.756B 0.00
Revolution Medicines (RVMD) United States $7.408B 0.00
Bio-Techne Corp (TECH) United States $7.334B 27.36
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.287B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.720B 12.86
Jazz Pharmaceuticals (JAZZ) Ireland $6.661B 6.42
Repligen (RGEN) United States $6.638B 74.31
Blueprint Medicines (BPMC) United States $6.555B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.390B 0.00
Telix Pharmaceuticals (TLX) Australia $5.610B 0.00
TG Therapeutics (TGTX) United States $5.488B 144.04
Legend Biotech (LEGN) United States $5.313B 0.00
Nuvalent (NUVL) United States $5.277B 0.00
Axsome Therapeutics (AXSM) United States $5.173B 0.00
ADMA Biologics Inc (ADMA) United States $4.875B 36.46
Alkermes (ALKS) Ireland $4.840B 12.99
Guardant Health (GH) United States $4.708B 0.00
Zealand Pharma (ZLDPF) Denmark $4.429B 0.00
Vaxcyte (PCVX) United States $4.198B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.967B 0.00
Merus (MRUS) Netherlands $3.816B 0.00
Sarepta Therapeutics (SRPT) United States $3.725B 0.00
Akero Therapeutics (AKRO) United States $3.696B 0.00
Avidity Biosciences (RNA) United States $3.686B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.679B 32.32
Cytokinetics (CYTK) United States $3.647B 0.00
PTC Therapeutics (PTCT) United States $3.640B 6.34
Krystal Biotech (KRYS) United States $3.614B 27.85
Arcellx (ACLX) United States $3.522B 0.00
SpringWorks Therapeutics (SWTX) United States $3.502B 0.00
Zai Lab (ZLAB) China $3.455B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.371B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.183B 0.00
Alvotech (ALVO) Luxembourg $3.099B 17.72
Viking Therapeutics (VKTX) United States $3.030B 0.00
Metsera (MTSR) United States $2.868B 0.00
Scholar Rock Holding (SRRK) United States $2.848B 0.00
Protagonist Therapeutics (PTGX) United States $2.830B 60.88
MoonLake Immunotherapeutics (MLTX) Switzerland $2.492B 0.00
Immunovant (IMVT) United States $2.456B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.336B 0.00
Ascentage Pharma Group - (AAPG) China $2.307B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.283B 0.00
ImmunityBio (IBRX) United States $2.233B 0.00
Apellis Pharmaceuticals (APLS) United States $2.192B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.180B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.089B 0.00
NovoCure (NVCR) Jersey $2.067B 0.00
Vericel (VCEL) United States $2.060B 1364.00
Bavarian Nordic (BVNRY) Denmark $2.011B 10.62
Harmony Biosciences Holdings (HRMY) United States $1.962B 13.04
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.962B 0.00
Ligand Pharmaceuticals (LGND) United States $1.960B 0.00
Denali Therapeutics (DNLI) United States $1.950B 0.00
Belite Bio (BLTE) United States $1.942B 0.00
CG Oncology (CGON) United States $1.939B 0.00
Kymera Therapeutics (KYMR) United States $1.920B 0.00
Amicus Therapeutics (FOLD) United States $1.915B 207.33
Certara (CERT) United States $1.853B 34.61
Apogee Therapeutics (APGE) United States $1.818B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.806B 0.00
Agios Pharmaceuticals (AGIO) United States $1.726B 0.00
Twist Bioscience (TWST) United States $1.693B 0.00
Beam Therapeutics (BEAM) United States $1.692B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.666B 0.00
IDEAYA Biosciences (IDYA) United States $1.648B 0.00
Disc Medicine (IRON) United States $1.641B 0.00
Biohaven (BHVN) United States $1.597B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.565B 0.00
Edgewise Therapeutics (EWTX) United States $1.495B 0.00
Janux Therapeutics (JANX) United States $1.492B 0.00
GRAIL (GRAL) United States $1.445B 0.00
BGM Group (BGM) China $1.425B 0.00
Structure Therapeutics (GPCR) United States $1.408B 0.00
Travere Therapeutics (TVTX) United States $1.407B 0.00
Mesoblast (MESO) Australia $1.386B 0.00
89BIO (ETNB) United States $1.385B 0.00
Adaptive Biotechnologies (ADPT) United States $1.357B 0.00
Celldex Therapeutics (CLDX) United States $1.351B 0.00
Liquidia Technologies (LQDA) United States $1.312B 0.00
Vera Therapeutics (VERA) United States $1.253B 0.00
MannKind (MNKD) United States $1.252B 25.75
ANI Pharmaceuticals (ANIP) United States $1.252B 12.90
Pacira BioSciences (PCRX) United States $1.192B 11.34
Dynavax Technologies (DVAX) United States $1.177B 70.00
Novavax (NVAX) United States $1.174B 2.74
Anbio Biotechnology (NNNN) Germany $1.108B 0.00
Viridian Therapeutics (VRDN) United States $1.107B 0.00
Mineralys Therapeutics (MLYS) United States $1.040B 0.00
MiMedx (MDXG) United States $0.979B 23.68
Arcus Biosciences (RCUS) United States $0.955B 0.00
NeoGenomics (NEO) United States $0.954B 0.00
Intellia Therapeutics (NTLA) United States $0.949B 0.00
Geron (GERN) United States $0.924B 0.00
CureVac (CVAC) Germany $0.918B 4.45
WAVE Life Sciences (WVE) Singapore $0.917B 0.00
Spyre Therapeutics (SYRE) United States $0.905B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.848B 0.00
CorMedix Inc (CRMD) United States $0.838B 56.18
Pharvaris (PHVS) Netherlands $0.836B 0.00
UniQure (QURE) Netherlands $0.830B 0.00
Oculis Holding AG (OCS) Switzerland $0.830B 0.00
Gyre Therapeutics (GYRE) United States $0.814B 217.00
Zymeworks (ZYME) United States $0.803B 0.00
LENZ Therapeutics (LENZ) United States $0.793B 0.00
Nuvation Bio (NUVB) United States $0.783B 0.00
Niagen Bioscience (NAGE) United States $0.778B 109.78
Praxis Precision Medicines (PRAX) United States $0.765B 0.00
Nurix Therapeutics (NRIX) United States $0.741B 0.00
Immunome (IMNM) United States $0.739B 0.00
Pharming Group (PHAR) Netherlands $0.706B 0.00
ArriVent BioPharma (AVBP) United States $0.698B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.670B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Replimune (REPL) United States $0.644B 0.00
Anavex Life Sciences (AVXL) United States $0.643B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.636B 0.00
Trevi Therapeutics (TRVI) United States $0.628B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Vir Biotechnology (VIR) United States $0.622B 0.00
Immatics (IMTX) Germany $0.621B 0.00
Arbutus Biopharma (ABUS) United States $0.617B 0.00
AnaptysBio (ANAB) United States $0.601B 0.00
Iovance Biotherapeutics (IOVA) United States $0.594B 0.00
Dianthus Therapeutics (DNTH) United States $0.593B 0.00
Keros Therapeutics (KROS) United States $0.592B 0.00
AbCellera Biologics (ABCL) Canada $0.588B 0.00
GH Research (GHRS) Ireland $0.581B 0.00
Sionna Therapeutics (SION) United States $0.561B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.557B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.552B 0.00
Cogent Biosciences (COGT) United States $0.549B 0.00
Eton Pharmaceuticals (ETON) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Stoke Therapeutics (STOK) United States $0.511B 11.85
Bicara Therapeutics (BCAX) United States $0.506B 0.00
Tyra Biosciences (TYRA) United States $0.493B 0.00
Upstream Bio (UPB) United States $0.493B 0.00
Kura Oncology (KURA) United States $0.488B 0.00
REGENXBIO (RGNX) United States $0.487B 0.00
Zenas BioPharma (ZBIO) United States $0.478B 0.00
Arvinas (ARVN) United States $0.475B 0.00
Castle Biosciences (CSTL) United States $0.465B 31.57
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Verastem (VSTM) United States $0.457B 0.00
Oric Pharmaceuticals (ORIC) United States $0.451B 0.00
Maze Therapeutics (MAZE) United States $0.450B 0.00
Sana Biotechnology (SANA) United States $0.449B 0.00
PureTech Health (PRTC) United States $0.437B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.410B 0.00
MeiraGTx Holdings (MGTX) United States $0.410B 0.00
Septerna (SEPN) United States $0.409B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.409B 0.00
Sage Therapeutics (SAGE) United States $0.409B 0.00
MBX Biosciences (MBX) United States $0.406B 0.00
Precigen (PGEN) United States $0.404B 0.00
Tectonic Therapeutic (TECX) United States $0.404B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.402B 0.00
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Celcuity (CELC) United States $0.395B 0.00
Rapport Therapeutics (RAPP) United States $0.395B 0.00
Humacyte (HUMA) United States $0.392B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.391B 0.00
Kamada (KMDA) Israel $0.381B 22.86
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Fortrea Holdings (FTRE) United States $0.367B 10.15
Checkpoint Therapeutics (CKPT) United States $0.365B 0.00
Myriad Genetics (MYGN) United States $0.360B 0.00
Abivax SA (ABVX) France $0.360B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.356B 0.00
Prothena (PRTA) Ireland $0.354B 0.00
Fulcrum Therapeutics (FULC) United States $0.348B 0.00
Emergent Biosolutions (EBS) United States $0.347B 0.00
Erasca (ERAS) United States $0.346B 0.00
Olema Pharmaceuticals (OLMA) United States $0.345B 0.00
Absci (ABSI) United States $0.339B 0.00
Benitec Biopharma (BNTC) United States $0.338B 0.00
ATyr Pharma (ATYR) United States $0.334B 0.00
Rezolute (RZLT) United States $0.333B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.331B 0.00
Abeona Therapeutics (ABEO) United States $0.328B 0.00
ITeos Therapeutics (ITOS) United States $0.328B 0.00
Alpha Teknova (TKNO) United States $0.319B 0.00
Cytek Biosciences (CTKB) United States $0.307B 0.00
Cidara Therapeutics (CDTX) United States $0.305B 0.00
XOMA Royalty (XOMA) United States $0.297B 0.00
Aura Biosciences (AURA) United States $0.296B 0.00
Inventiva S.A (IVA) France $0.296B 0.00
Compass Therapeutics (CMPX) United States $0.289B 0.00
Entrada Therapeutics (TRDA) United States $0.285B 9.26
Prima BioMed (IMMP) Australia $0.283B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.281B 0.00
Gossamer Bio (GOSS) United States $0.273B 0.00
Tvardi Therapeutics (TVRD) United States $0.272B 0.00
Candel Therapeutics (CADL) United States $0.272B 0.00
Ocugen (OCGN) United States $0.272B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Terns Pharmaceuticals (TERN) United States $0.264B 0.00
Palvella Therapeutics (PVLA) United States $0.262B 0.00
Inozyme Pharma (INZY) United States $0.256B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.255B 0.00
Lifecore Biomedical (LFCR) United States $0.249B 0.00
Atea Pharmaceuticals (AVIR) United States $0.248B 0.00
Neurogene (NGNE) United States $0.246B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.244B 49.62
ADC Therapeutics SA (ADCT) Switzerland $0.241B 0.00
Semper Paratus Acquisition (TVGN) United States $0.241B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.239B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.238B 0.00
Cartesian Therapeutics (RNAC) United States $0.238B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
MaxCyte (MXCT) United States $0.233B 0.00
Allogene Therapeutics (ALLO) United States $0.232B 0.00
Annexon (ANNX) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.231B 0.00
DBV Technologies S.A (DBVT) France $0.230B 0.00
Alumis (ALMS) United States $0.230B 0.00
Amarin (AMRN) Ireland $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Aardvark Therapeutics (AARD) United States $0.228B 0.00
Astria Therapeutics (ATXS) United States $0.221B 0.00
Solid Biosciences (SLDB) United States $0.218B 0.00
Adherex Technologies (FENC) United States $0.217B 0.00
Monopar Therapeutics (MNPR) United States $0.217B 0.00
Design Therapeutics (DSGN) United States $0.216B 0.00
EnGene Holdings (ENGN) Canada $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
GENFIT S.A (GNFT) France $0.211B 0.00
Nuvectis Pharma (NVCT) United States $0.205B 0.00
Bright Minds Biosciences (DRUG) United States $0.204B 0.00
Actuate Therapeutics (ACTU) United States $0.203B 0.00
Cardiff Oncology (CRDF) United States $0.202B 0.00
BioStem Technologies (BSEM) $0.200B 8.15
Tango Therapeutics (TNGX) United States $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Codexis (CDXS) United States $0.199B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.196B 0.00
Urogen Pharma (URGN) United States $0.193B 0.00
CARGO Therapeutics (CRGX) United States $0.189B 0.00
Galena Biopharma (SLS) United States $0.189B 0.00
Inhibrx Biosciences (INBX) United States $0.186B 0.11
Tiziana Life Sciences (TLSA) United Kingdom $0.185B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.183B 0.00
Kodiak Sciences (KOD) United States $0.182B 0.00
CytomX Therapeutics (CTMX) United States $0.180B 4.65
ProQR Therapeutics (PRQR) Netherlands $0.176B 0.00
ScPharmaceuticals (SCPH) United States $0.175B 0.00
DiaMedica Therapeutics (DMAC) United States $0.174B 0.00
AC Immune (ACIU) Switzerland $0.170B 0.00
Prime Medicine (PRME) United States $0.169B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Rapt Therapeutics (RAPT) United States $0.163B 0.00
Voyager Therapeutics (VYGR) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
Puma Biotechnology (PBYI) United States $0.161B 4.20
Alpha Cognition (ACOG) Canada $0.146B 0.00
BioAge Labs (BIOA) United States $0.146B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.139B 0.00
Instil Bio (TIL) United States $0.138B 0.00
Fate Therapeutics (FATE) United States $0.133B 0.00
Greenwich LifeSciences (GLSI) United States $0.131B 0.00
Editas Medicine (EDIT) United States $0.130B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.126B 0.00
EXoZymes (EXOZ) United States $0.125B 0.00
InflaRx (IFRX) Germany $0.124B 0.00
Nkarta (NKTX) United States $0.124B 0.00
Alector (ALEC) United States $0.124B 0.00
TuHURA Biosciences (HURA) United States $0.124B 0.00
Seer (SEER) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.121B 0.00
Ventyx Biosciences (VTYX) United States $0.120B 0.00
Black Diamond Therapeutics (BDTX) United States $0.114B 33.50
Sangamo Therapeutics (SGMO) United States $0.110B 0.00
Neumora Therapeutics (NMRA) United States $0.110B 0.00
Sagimet Biosciences (SGMT) United States $0.106B 0.00
Agenus (AGEN) United States $0.105B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.103B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
Medicus Pharma (MDCX) United States $0.098B 0.00
Kyverna Therapeutics (KYTX) United States $0.098B 0.00
C4 Therapeutics (CCCC) United States $0.098B 0.00
Genelux (GNLX) United States $0.097B 0.00
Caribou Biosciences (CRBU) United States $0.095B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Nautilus Biotechnology (NAUT) United States $0.092B 0.00
Contineum Therapeutics (CTNM) United States $0.092B 0.00
Elicio Therapeutics (ELTX) United States $0.091B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Cabaletta Bio (CABA) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
23andMe Holding (MEHCQ) United States $0.089B 0.00
Immunic (IMUX) United States $0.088B 0.00
Coherus BioSciences (CHRS) United States $0.088B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.086B 0.00
Adagene (ADAG) China $0.086B 0.00
Senti Biosciences (SNTI) United States $0.083B 0.00
Whitehawk Therapeutics (WHWK) United States $0.083B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.082B 0.00
Alto Neuroscience (ANRO) United States $0.082B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
I-Mab (IMAB) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
IO Biotech (IOBT) Denmark $0.080B 0.00
Pliant Therapeutics (PLRX) United States $0.079B 0.00
TScan Therapeutics (TCRX) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.078B 0.00
Genenta Science S.p.A (GNTA) Italy $0.077B 0.00
IGM Biosciences (IGMS) United States $0.075B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Inovio Pharmaceuticals (INO) United States $0.072B 0.00
PDS Biotechnology (PDSB) United States $0.072B 0.00
Jasper Therapeutics (JSPR) United States $0.072B 0.00
Elutia (ELUT) United States $0.071B 0.00
Tenaya Therapeutics (TNYA) United States $0.070B 0.00
Zura Bio (ZURA) United States $0.070B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Adlai Nortye (ANL) Cayman Islands $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Seres Therapeutics (MCRB) United States $0.067B 0.00
Citius Oncology (CTOR) United States $0.065B 0.00
Exicure (XCUR) United States $0.063B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.062B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Skye Bioscience (SKYE) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.058B 0.00
Adicet Bio (ACET) United States $0.057B 0.00
TELA Bio (TELA) United States $0.057B 0.00
VTv Therapeutics (VTVT) United States $0.057B 0.00
Repare Therapeutics (RPTX) Canada $0.057B 0.00
Renovaro (RENB) United States $0.056B 0.00
Forte Biosciences (FBRX) United States $0.056B 0.00
Biomea Fusion (BMEA) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
Immuneering (IMRX) United States $0.055B 0.00
Ikena Oncology (IKNA) United States $0.055B 0.00
Celularity (CELU) United States $0.055B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.053B 0.00
Kalaris Therapeutics (KLRS) United States $0.052B 0.00
Shattuck Labs (STTK) United States $0.052B 0.00
Werewolf Therapeutics (HOWL) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Quince Therapeutics (QNCX) United States $0.050B 0.00
Cue Biopharma (CUE) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
PepGen (PEPG) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.046B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
Rein Therapeutics (RNTX) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
RenovoRx (RNXT) United States $0.044B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.043B 0.00
Atara Biotherapeutics (ATRA) United States $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Kronos Bio (KRON) United States $0.042B 0.00
Connect Biopharma Holdings (CNTB) United States $0.042B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Spero Therapeutics (SPRO) United States $0.039B 0.00
Annovis Bio (ANVS) United States $0.039B 0.00
Alterity Therapeutics - (ATHE) Australia $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
Boundless Bio (BOLD) United States $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Aligos Therapeutics (ALGS) United States $0.034B 0.00
Scilex Holding (SCLX) United States $0.032B 0.00
Quantum Biopharma (QNTM) Canada $0.031B 0.00
FibroBiologics (FBLG) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
OnKure Therapeutics (OKUR) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.026B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
CalciMedica (CALC) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Advanced Biomed (ADVB) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Passage Bio (PASG) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Vor Biopharma (VOR) $0.022B 0.00
Clene (CLNN) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Imunon (IMNN) United States $0.020B 0.00
Ovid Therapeutics (OVID) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
ABVC BioPharma (ABVC) United States $0.020B 0.00
Lexaria Bioscience (LEXX) Canada $0.019B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
HOOKIPA Pharma (HOOK) United States $0.018B 0.00
X4 Pharmaceuticals (XFOR) United States $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Cingulate (CING) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Equillium (EQ) United States $0.015B 0.00
NextCure (NXTC) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.011B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sensei Biotherapeutics (SNSE) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00